Giants' Bullpen Depth Tested as Winn Lands on IL After Heavy Usage

By Ty Whitney ·

A third consecutive day of work exposed an elbow vulnerability in San Francisco's relief core, forcing a mid-June recalibration.

Giants' Bullpen Depth Tested as Winn Lands on IL After Heavy Usage

Keaton Winn joined the injured list Sunday with a right elbow strain, less than a week after pitching in three straight games—his first such stretch of the 2026 season. The 28-year-old reliever last took the mound Monday, June 9, against Washington, blowing a save after surrendering three runs over two-thirds of an inning in his third consecutive outing. He felt soreness during a catch session Saturday and underwent an MRI that revealed the strain. Manager Tony Vitello indicated the shutdown should be brief—a "handful" of days before Winn resumes throwing—but the timing underscores a familiar pattern for a pitcher whose arm durability has been a career-long concern.

Winn's injury history reads like a cautionary tale about pitch design and workload compression. He missed all of 2021 following Tommy John surgery, then landed on the IL twice in 2024 before undergoing a season-ending ulnar nerve transposition procedure. Last season brought shoulder inflammation at Triple-A Sacramento. The Giants shifted him to relief this year explicitly to preserve his health, yet he became one of the bullpen's most-relied-upon arms—tied for most appearances (29) on the staff with a 3.23 ERA over 30 2/3 innings. Vitello acknowledged that Winn's split-finger fastball demands extra recovery time, and that the reliever lacked full availability in back-to-back outings at times. Still, the manager defended the usage decision, noting that Winn indicated he was healthy enough to pitch Monday and that the team's daily bullpen meetings account for pitcher readiness.

Tristan Beck, recalled from Triple-A Sacramento on Sunday, becomes the short-term fill. The more significant relief piece arrives when left-hander Matt Gage clears his own IL stint. Gage has been sidelined since June 1 with right knee inflammation but threw 1⅔ scoreless innings in a rehab appearance with Single-A San Jose on Saturday. The Giants expect to activate him when they travel to Atlanta this week, which would shore up the back of a relief corps that now faces thinned depth through at least the 15-day minimum of Winn's absence.

For bettors, Winn's absence removes a high-leverage arm during a critical stretch. Over his last 15 appearances before landing on the IL, Winn logged a 2.95 ERA with 13 strikeouts in 15⅓ innings—a mid-tier production level masked by high usage. The Giants' bullpen win probability added (WPA) per appearance tends to decline when Winn is unavailable, particularly in save situations where his velocity remains acceptable despite durability concerns. San Francisco's moneyline odds will price in the short-term relief shortage; the market won't reward unders in close games against Atlanta until Gage returns. However, for the 48-72 hours before Gage is activated, the Giants' late-inning options narrow enough to favor opponents in leverage spots. Beck's track record—a mid-4s ERA over 25 Triple-A appearances this season—doesn't compensate for Winn's removal at the top of the bullpen queue.